Jeffrey S Ross

Jeffrey S Ross

UNVERIFIED PROFILE

Are you Jeffrey S Ross?   Register this Author

Register author
Jeffrey S Ross

Jeffrey S Ross

Publications by authors named "Jeffrey S Ross"

Are you Jeffrey S Ross?   Register this Author

100Publications

3696Reads

38Profile Views

Clinical and Immunological Implications of Frameshift Mutations in Lung Cancer.

J Thorac Oncol 2019 Oct 22;14(10):1807-1817. Epub 2019 Jun 22.

Leonard M. Miller School of Medicine, University of Miami, Miami, Florida; Memorial Sloan Kettering Cancer Center, New York, New York; Weill Cornell Medical College, New York, New York. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jtho.2019.06.016DOI Listing
October 2019

Improving the Prognostic Ability for Personalized Therapeutic Approaches in Nonseminomatous Germ Cell Tumors.

J Clin Oncol 2019 Sep 30;37(26):2314-2316. Epub 2019 Jul 30.

Moffitt Cancer Center and Research Institute, Tampa, FL.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.19.01672DOI Listing
September 2019

Pan-Cancer Analysis of Loss-of-Function Alterations and Their Association with the Focal Tandem-Duplicator Phenotype.

Oncologist 2019 Jul 10. Epub 2019 Jul 10.

Johns Hopkins University School of Medicine and Bloomberg-Kimmel Institute for Cancer Immunotherapy, Baltimore, Maryland, USA

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1634/theoncologist.2019-0214DOI Listing
July 2019

Dual Targeting of EGFR and IGF1R in the TNFAIP8 Knockdown Non-Small Cell Lung Cancer Cells.

Mol Cancer Res 2019 May 15;17(5):1207-1219. Epub 2019 Jan 15.

Georgetown Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, DC.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1541-7786.MCR-18-0731DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6497573PMC
May 2019

Phosphatidylinositol 3-kinase pathway genomic alterations in 60,991 diverse solid tumors informs targeted therapy opportunities.

Cancer 2019 Apr 24;125(7):1185-1199. Epub 2018 Dec 24.

Center for Personalized Cancer Therapy and Division of Hematology and Oncology, University of California San Diego, San Diego, California.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.31921DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6433468PMC
April 2019

Comprehensive genetic alteration profiling in primary and recurrent glioblastoma.

J Neurooncol 2019 Mar 9;142(1):111-118. Epub 2018 Dec 9.

Fred & Pamela Buffett Cancer Center, University of Nebraska Medical Center, Omaha, NE, USA.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s11060-018-03070-2
Publisher Site
http://dx.doi.org/10.1007/s11060-018-03070-2DOI Listing
March 2019

Detection of Known and Novel FGFR Fusions in Non-Small Cell Lung Cancer by Comprehensive Genomic Profiling.

J Thorac Oncol 2019 01 26;14(1):54-62. Epub 2018 Sep 26.

Department of Medicine, Division of Hematology and Oncology, University of Michigan, Ann Arbor, Michigan. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jtho.2018.09.014DOI Listing
January 2019

Myeloid cell leukemia-1 protein expression and myeloid cell leukemia-1 gene amplification in non small cell lung cancer.

Indian J Pathol Microbiol 2018 Jan-Mar;61(1):27-30

Department of Pathology, Albany Medical Center, Albany, New York, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4103/IJPM.IJPM_731_16DOI Listing
November 2018

Pembrolizumab as Neoadjuvant Therapy Before Radical Cystectomy in Patients With Muscle-Invasive Urothelial Bladder Carcinoma (PURE-01): An Open-Label, Single-Arm, Phase II Study.

J Clin Oncol 2018 Oct 20:JCO1801148. Epub 2018 Oct 20.

Andrea Necchi, Andrea Anichini, Daniele Raggi, Simona Massa, Maurizio Colecchia, Patrizia Giannatempo, Roberta Mortarini, Elena Farè, Francesco Monopoli, Antonella Messina, Roberto Salvioni, and Luigi Mariani, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico, Istituto Nazionale dei Tumori; Alberto Briganti, Roberta Lucianò, Marco Bianchi, Renzo Colombo, Andrea Gallina, Andrea Salonia, and Francesco Montorsi, Vita Salute San Raffaele University and Urological Research Institute, Istituto di Ricovero e Cura a Carattere Scientifico San Raffaele Hospital, Milan, Italy; Siraj M. Ali, Russell Madison, Jeffrey S. Ross, and Jon H. Chung, Foundation Medicine, Cambridge, MA; and Jeffrey S. Ross, Upstate Medical University, Syracuse, NY.

View Article

Download full-text PDF

Source
http://ascopubs.org/doi/10.1200/JCO.18.01148
Publisher Site
http://dx.doi.org/10.1200/JCO.18.01148DOI Listing
October 2018

Genetic Analysis of 779 Advanced Differentiated and Anaplastic Thyroid Cancers.

Clin Cancer Res 2018 07 3;24(13):3059-3068. Epub 2018 Apr 3.

Department of Pharmaceutical Sciences, Skaags School of Pharmacy and Pharmaceutical Sciences, University of Colorado Anschutz Medical Campus, Aurora, Colorado.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-18-0373DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6030480PMC
July 2018

Mutations and PD-1 Inhibitor Resistance in -Mutant Lung Adenocarcinoma.

Cancer Discov 2018 07 17;8(7):822-835. Epub 2018 May 17.

Department of Thoracic and Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/2159-8290.CD-18-0099DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6030433PMC
July 2018

Analysis of Amplification: Next-Generation Sequencing of Patients With Diverse Malignancies.

JCO Precis Oncol 2018 13;2018. Epub 2018 Jul 13.

University of California, San Diego, Moores Cancer Center, La Jolla.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6106866PMC
http://dx.doi.org/10.1200/PO.17.00235DOI Listing
July 2018

Impact of EML4-ALK Variant on Resistance Mechanisms and Clinical Outcomes in ALK-Positive Lung Cancer.

J Clin Oncol 2018 04 26;36(12):1199-1206. Epub 2018 Jan 26.

Jessica J. Lin, Satoshi Yoda, Beow Y. Yeap, Ibiayi Dagogo-Jack, Nicholas A. Jessop, Ginger Y. Jiang, Long P. Le, Aaron N. Hata, Justin F. Gainor, Anthony J. Iafrate, and Alice T. Shaw, Massachusetts General Hospital, Boston; Alexa B. Schrock, Kyle Gowen, Philip J. Stephens, Jeffrey S. Ross, Siraj M. Ali, and Vincent A. Miller, Foundation Medicine, Cambridge, MA; Viola W. Zhu and Sai-Hong Ignatius Ou, Chao Family Comprehensive Cancer Center, University of California Irvine School of Medicine, Orange, CA; Melissa L. Johnson, Sarah Cannon Research Institute; and Christine M. Lovly, Vanderbilt-Ingram Cancer Center, Nashville, TN.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2017.76.2294DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5903999PMC
April 2018

Reply to Genomic profiles of nasopharyngeal carcinoma: The importance of histological subtyping and Epstein-Barr virus in situ assays.

Cancer 2018 01 22;124(2):435-436. Epub 2017 Nov 22.

OrigiMed Inc, Shanghai, China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.31132DOI Listing
January 2018

Genomic Profiling of Small-Bowel Adenocarcinoma.

JAMA Oncol 2017 Nov;3(11):1546-1553

Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jamaoncol.2017.1051DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5710195PMC
November 2017

Response to Pembrolizumab in a Patient With Chemotherapy Refractory Bladder Cancer With Small Cell Variant Histology: A Case Report and Review of the Literature.

Clin Genitourin Cancer 2017 06 22;15(3):e521-e524. Epub 2016 Dec 22.

Department of Medical Oncology, Sidney Kimmel Cancer Center, Jefferson University Hospital, Philadelphia, PA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clgc.2016.12.012DOI Listing
June 2017

The potential role of comprehensive genomic profiling to guide targeted therapy for patients with biliary cancer.

Therap Adv Gastroenterol 2017 Jun 28;10(6):507-520. Epub 2017 Mar 28.

Department of Pathology and Laboratory Medicine, Albany Medical College, Albany, NY, USA Foundation Medicine, Cambridge, MA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/1756283X17698090DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5424872PMC
June 2017

Comprehensive genomic sequencing and the molecular profiles of clinically advanced breast cancer.

Pathology 2017 Feb 26;49(2):120-132. Epub 2016 Dec 26.

Foundation Medicine, Inc., Cambridge, MA, United States.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.pathol.2016.11.005DOI Listing
February 2017

Next-Generation Sequencing Reveals Pathway Activations and New Routes to Targeted Therapies in Cutaneous Metastatic Melanoma.

Am J Dermatopathol 2017 Jan;39(1):1-13

*Professor of Pathology and Dermatology, Albany Medical College, Albany, NY; †Pathology Resident, Unversidade Estadual Paulista, Botucatu, Brazil; ‡Pathology Resident, Albany Medical College, Albany, NY; §Director of Research, Associate Professor, Department of Pathology, Albany, Medical College, Albany, NY; ¶Research and Development, Foundation Medicine, Inc, Cambridge, MA; ‖Chief Medical Officer, Foundation Medicine, Inc, Cambridge, MA; #Chief Scientific Officer, Foundation Medicine, Inc, Cambridge, MA; **Associate Medical Officer, Foundation Medicine, Inc, Cambridge, MA; ††Associate Medical Director, Foundation Medicine, Inc, Cambridge, MA; ‡‡Research Scientist, Foundation Medicine, Inc, Cambridge, MA; §§Chief, Professor of Pathology, Albany, Medical College, Albany, NY; and ¶¶Medical Director, Foundation Medicine, Inc, Cambridge, MA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/DAD.0000000000000729DOI Listing
January 2017

Correlation Between Molecular Subclassifications of Clear Cell Renal Cell Carcinoma and Targeted Therapy Response.

Eur Urol Focus 2016 Jun 9;2(2):204-209. Epub 2015 Dec 9.

Department of Medical Oncology and Experimental Therapeutics, City of Hope Comprehensive Cancer Center, Duarte, CA, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.euf.2015.11.007DOI Listing
June 2016